CN105055769A - Preparation method and application of Liuwei Dihuang pills - Google Patents

Preparation method and application of Liuwei Dihuang pills Download PDF

Info

Publication number
CN105055769A
CN105055769A CN201510434596.0A CN201510434596A CN105055769A CN 105055769 A CN105055769 A CN 105055769A CN 201510434596 A CN201510434596 A CN 201510434596A CN 105055769 A CN105055769 A CN 105055769A
Authority
CN
China
Prior art keywords
concentrated
colourless
washed
liuwei dihuang
collect eluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510434596.0A
Other languages
Chinese (zh)
Other versions
CN105055769B (en
Inventor
周勤文
陈家进
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TONGRENTANG PHARMACEUTICAL CO Ltd
Original Assignee
TONGRENTANG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TONGRENTANG PHARMACEUTICAL CO Ltd filed Critical TONGRENTANG PHARMACEUTICAL CO Ltd
Priority to CN201510434596.0A priority Critical patent/CN105055769B/en
Publication of CN105055769A publication Critical patent/CN105055769A/en
Application granted granted Critical
Publication of CN105055769B publication Critical patent/CN105055769B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicine preparations and particularly relates to a preparation method of Liuwei Dihuang pills. The Liuwei Dihuang pills are made from 120g of prepared rehmannia root, 60g of common Macrocarpium fruit, 45g of root-bark of tree peony, 60g of common yam rhizome, 45g of Indian bread and 45g of rhizome of oriental water plantain. The Liuwei Dihuang pills are prepared with macroporous resin, cation exchange resin and anion exchange resin, so that contents are greatly increased and less usage is required. The invention further provides application of the Liuwei Dihuang pills in the preparation of medicaments for inhibiting proliferation of mouse embryonic fibroblast NIH3T3.

Description

A kind of preparation method of LIUWEI DIHUANG WAN and application
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to a kind of preparation method and application of LIUWEI DIHUANG WAN.
Background technology
LIUWEI DIHUANG WAN is recorded in Ministry of Public Health standard, is made up, decocts with water, make pill of Radix Rehmanniae Preparata 120g, Fructus Corni 60g, Cortex Moutan 45g, Rhizoma Dioscoreae 60g, Poria 45g, Rhizoma Alismatis 45g as crude drug.Enriching yin and nourishing kidney.For damage of kidney-YIN, dizziness and tinnitus, soreness of the waist and knees, osteopyrexia and fever, night sweat is passed out semen.In prior art, not yet have LIUWEI DIHUANG WAN extracting the report adopting resin technology in preparation, and adopt the method for soak by water, technique is coarse, backward, and impurity is many, causes patient's consumption excessive, is inconvenient to take, and has had a strong impact on this product and has applied clinically.
In prior art, the heavy 1.44g of every 8 balls of former LIUWEI DIHUANG WAN, 8 balls, 3 times on the one, the heavy 1.2g of every 8 balls of the LIUWEI DIHUANG WAN adopting the present invention to be prepared into, but its active component contained increases greatly.
Summary of the invention
Goal of the invention: in order to solve the problem, the object of the present invention is to provide a kind of preparation method of LIUWEI DIHUANG WAN.
Another object of the present invention is to provide a kind of LIUWEI DIHUANG WAN to suppress the application in mouse embryo fibroblasts NIH3T3 hyperproliferation agent in preparation.
Technical scheme: the object of the invention is by following scheme realize:
A kind of preparation method of LIUWEI DIHUANG WAN, by Radix Rehmanniae Preparata 120g, Fructus Corni 60g, Cortex Moutan 45g, Rhizoma Dioscoreae 60g, Poria 45g, Rhizoma Alismatis 45g makes as crude drug, described method is made up of the following step: get Radix Rehmanniae Preparata 120g, Fructus Corni 60g, Cortex Moutan 45g, Rhizoma Dioscoreae 60g, Poria 45g, Rhizoma Alismatis 45g, add 8 times amount distilled water extraction twice, each 1.5 hours, merge extractive liquid, be concentrated into 0.4ml/g crude drug, adding ethanol makes alcohol content reach 80%, leave standstill 8 hours, sucking filtration, get supernatant, D1010 type macroporous adsorptive resins crossed by medicinal liquid, be washed to colourless, use 90% ethanol elution, collect eluent 10BV, namely evaporate to dryness obtains aminoacyl site, concentrated by water lotion after crossing macroporous resin, upper 732 type cation exchange resiies after medicinal liquid adjust ph to 2, are washed to colourless, and with 40% ethanol elution containing 3% ammonia, collect eluent, namely evaporate to dryness obtains B position, finally the water lotion crossing cationic resin is concentrated, upper 717 type anion exchange resin after adjust ph to 8, be washed to colourless, after concentrated hydrochloric acid desorption, use 40% ethanol elution, collect eluent, namely evaporate to dryness obtains C position, finally by three amount of powder mix homogeneously, pill, dry, polishing, the heavy 1.2g of every 8 balls.
Described LIUWEI DIHUANG WAN suppresses the application in mouse embryo fibroblasts NIH3T3 hyperproliferation agent in preparation, described method is made up of the following step: get Radix Rehmanniae Preparata 120g, Fructus Corni 60g, Cortex Moutan 45g, Rhizoma Dioscoreae 60g, Poria 45g, Rhizoma Alismatis 45g, add 8 times amount distilled water extraction twice, each 1.5 hours, merge extractive liquid, be concentrated into 0.4ml/g crude drug, adding ethanol makes alcohol content reach 80%, leave standstill 8 hours, sucking filtration, get supernatant, D1010 type macroporous adsorptive resins crossed by medicinal liquid, be washed to colourless, use 90% ethanol elution, collect eluent 10BV, namely evaporate to dryness obtains aminoacyl site, concentrated by water lotion after crossing macroporous resin, upper 732 type cation exchange resiies after medicinal liquid adjust ph to 2, are washed to colourless, and with 40% ethanol elution containing 3% ammonia, collect eluent, namely evaporate to dryness obtains B position, finally the water lotion crossing cationic resin is concentrated, upper 717 type anion exchange resin after adjust ph to 8, be washed to colourless, after concentrated hydrochloric acid desorption, use 40% ethanol elution, collect eluent, namely evaporate to dryness obtains C position, finally by three amount of powder mix homogeneously, pill, dry, polishing, the heavy 1.2g of every 8 balls.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
Embodiment 1: get Radix Rehmanniae Preparata 120g, Fructus Corni 60g, Cortex Moutan 45g, Rhizoma Dioscoreae 60g, Poria 45g, Rhizoma Alismatis 45g, adds 8 times amount distilled water extraction twice, each 1.5 hours, merge extractive liquid, is concentrated into 0.4ml/g crude drug, adds ethanol and makes alcohol content reach 80%, leave standstill 8 hours, sucking filtration, gets supernatant, and D1010 type macroporous adsorptive resins crossed by medicinal liquid, be washed to colourless, use 90% ethanol elution, collect eluent 10BV, namely evaporate to dryness obtains aminoacyl site; Concentrated by water lotion after crossing macroporous resin, upper 732 type cation exchange resiies after medicinal liquid adjust ph to 2, are washed to colourless, and with 40% ethanol elution containing 3% ammonia, collect eluent, namely evaporate to dryness obtains B position; Finally the water lotion crossing cationic resin is concentrated, upper 717 type anion exchange resin after adjust ph to 8, be washed to colourless, after concentrated hydrochloric acid desorption, use 40% ethanol elution, collect eluent, namely evaporate to dryness obtains C position, finally by three amount of powder mix homogeneously, pill, dry, polishing, the heavy 1.2g of every 8 balls.
Embodiment 2: LIUWEI DIHUANG WAN suppresses the experimentation data of mouse embryo fibroblasts NIH3T3 propagation
1 experiment material
1.1 experiment cell strain: mouse embryo fibroblasts NIH3T3, Nanjing Tongrentang Pharmaceutical Co., Ltd.'s laboratory cell storehouse, DMEM+10%FBS cellar culture.
1.2 Experimental agents: drugs: LIUWEI DIHUANG WAN of the present invention: prepare by embodiment 1 method.Medicinal liquid liquid storage: take 100mg LIUWEI DIHUANG WAN, is dissolved in 5ml dehydrated alcohol, 0.2 μm of frit, 500 μ ldoff pipe subpackages ,-20 DEG C of storages, and simultaneously 0.2 μm of frit dehydrated alcohol is in order to the use of matched group.
1.3 experiment reagents: DMEM (GIBCO company Cat.No.12100-061Lot.No.758137); Hyclone (Tian Hang bio tech ltd, Zhejiang Lot.No.100419); NaHCO3 (Shanghai hundred million chemical reagent company limited Cat.No.11810-033Lot.No.1088387 of a specified duration); Trypsin (AMRESCO company lot number: 2010/04); EDTA (AMRESCO company lot number: 2009/10); PenicillinGSodiumSalt (AMRESCO company lot number: 2010242); StreptomycinSulfate (AMRESCO company lot number: 2010382); Dehydrated alcohol (Nanjing Chemistry Reagent Co., Ltd.'s lot number: 080310182); MTT (Biosharp lot number: 0793); PBS (laboratory autogamy);
1.4 experiment equipments: Lycra inverted microscope (German Leica model: DM1L); Visible-ultraviolet light microwell plate detector (MD company of U.S. model: SPECTRAMAX190); CO2 incubator (FORMA model: 3111); Super-clean bench (safe and sound Inc. of Su Jing group moulding number: SW-CJ-ZFD); Pure water instrument (Spring company of U.S. model: S/N020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Table electrothermal air dry oven (the accurate experimental facilities company in Shanghai model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μm of filter (MILLIPORE model: SLGP033RB); 10cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2 experimental techniques: 1) mouse embryo fibroblasts NIH3T3 DMEM+10%FBS in 37 DEG C, 5%CO2 carries out cellar culture (10cm culture dish), when Growth of Cells is to logarithmic (log) phase, collecting cell, discard culture fluid, PBS fine laundering 3 times, add 3ml0.25% trypsin-0.04%EDTA, after 37 DEG C of digestion 2min, add 5ml complete medium neutralization reaction wherein, proceeded in centrifuge tube after piping and druming cell, the centrifugal 5min of 1000rpm, adjustment concentration of cell suspension 3 × 104/ml.2) enter in 96 well culture plates by cell kind, every hole adds cell suspension 180 μ l, and culture plate puts into cell culture incubator (37 DEG C, 5%CO2) cellar culture.3) according to cell growth status, generally grow to 50%-70%, add LIUWEI DIHUANG WAN solution, continue to cultivate 24h.4) add 20 μ lMTT solution (5mg/ml, i.e. 0.5%MTT) after 24h, continue to cultivate 4h.5) after 4h, buckle method removes supernatant, pats dry gently with absorbent paper, and every hole adds 200 μ l dimethyl sulfoxide, puts low-speed oscillation 10min on shaking table, crystal is fully dissolved.The light absorption value in each hole is measured at enzyme-linked immunosorbent assay instrument 490nm place.6) background (do not add cell, only add culture fluid) is set, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide) simultaneously, often organizes the multiple hole of setting 6.7) result represents with the suppression ratio of medicine to cell: cell proliferation suppression ratio (%)=(control wells OD value-dosing holes OD value)/control wells OD value × 100%.Experiment repetition 3 times.
3 experimental results: statistical result showed after mtt assay experiment, compare with matched group, when dosage reaches 5mg/ml, to mouse embryo fibroblasts NIH3T3 Proliferation Ability variant (P<0.05), dosage this difference when 10mg/ml has significance (P<0.01), has pole significant difference (P<0.001) when dosage reaches 15-20mg/ml.
Table 1 LIUWEI DIHUANG WAN is to mouse embryo fibroblasts NIH3T3 Proliferation Ability influence research (X ± SD)
Note: compare with matched group, * P<0.01; * P<0.001
4 experiment conclusion: LIUWEI DIHUANG WAN can suppress mouse embryo fibroblasts NIH3T3 to breed, reduce the Growth of Cells number of mouse embryo fibroblasts NIH3T3, this effect is dose dependent.

Claims (2)

1. the preparation method of a LIUWEI DIHUANG WAN, by Radix Rehmanniae Preparata 120g, Fructus Corni 60g, Cortex Moutan 45g, Rhizoma Dioscoreae 60g, Poria 45g, Rhizoma Alismatis 45g makes as crude drug, it is characterized in that described method is made up of the following step: get Radix Rehmanniae Preparata 120g, Fructus Corni 60g, Cortex Moutan 45g, Rhizoma Dioscoreae 60g, Poria 45g, Rhizoma Alismatis 45g, add 8 times amount distilled water extraction twice, each 1.5 hours, merge extractive liquid, be concentrated into 0.4ml/g crude drug, adding ethanol makes alcohol content reach 80%, leave standstill 8 hours, sucking filtration, get supernatant, D1010 type macroporous adsorptive resins crossed by medicinal liquid, be washed to colourless, use 90% ethanol elution, collect eluent 10BV, namely evaporate to dryness obtains aminoacyl site, concentrated by water lotion after crossing macroporous resin, upper 732 type cation exchange resiies after medicinal liquid adjust ph to 2, are washed to colourless, and with 40% ethanol elution containing 3% ammonia, collect eluent, namely evaporate to dryness obtains B position, finally the water lotion crossing cationic resin is concentrated, upper 717 type anion exchange resin after adjust ph to 8, be washed to colourless, after concentrated hydrochloric acid desorption, use 40% ethanol elution, collect eluent, namely evaporate to dryness obtains C position, finally by three amount of powder mix homogeneously, pill, dry, polishing, the heavy 1.2g of every 8 balls.
2. LIUWEI DIHUANG WAN suppresses the application in mouse embryo fibroblasts NIH3T3 hyperproliferation agent in preparation according to claim 1, it is characterized in that described method is made up of the following step: get Radix Rehmanniae Preparata 120g, Fructus Corni 60g, Cortex Moutan 45g, Rhizoma Dioscoreae 60g, Poria 45g, Rhizoma Alismatis 45g, add 8 times amount distilled water extraction twice, each 1.5 hours, merge extractive liquid, be concentrated into 0.4ml/g crude drug, adding ethanol makes alcohol content reach 80%, leave standstill 8 hours, sucking filtration, get supernatant, D1010 type macroporous adsorptive resins crossed by medicinal liquid, be washed to colourless, use 90% ethanol elution, collect eluent 10BV, namely evaporate to dryness obtains aminoacyl site, concentrated by water lotion after crossing macroporous resin, upper 732 type cation exchange resiies after medicinal liquid adjust ph to 2, are washed to colourless, and with 40% ethanol elution containing 3% ammonia, collect eluent, namely evaporate to dryness obtains B position, finally the water lotion crossing cationic resin is concentrated, upper 717 type anion exchange resin after adjust ph to 8, be washed to colourless, after concentrated hydrochloric acid desorption, use 40% ethanol elution, collect eluent, namely evaporate to dryness obtains C position, finally by three amount of powder mix homogeneously, pill, dry, polishing, the heavy 1.2g of every 8 balls.
CN201510434596.0A 2015-07-22 2015-07-22 A kind of preparation method and application of Liuwei Dihuang Wan Active CN105055769B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510434596.0A CN105055769B (en) 2015-07-22 2015-07-22 A kind of preparation method and application of Liuwei Dihuang Wan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510434596.0A CN105055769B (en) 2015-07-22 2015-07-22 A kind of preparation method and application of Liuwei Dihuang Wan

Publications (2)

Publication Number Publication Date
CN105055769A true CN105055769A (en) 2015-11-18
CN105055769B CN105055769B (en) 2017-11-10

Family

ID=54485446

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510434596.0A Active CN105055769B (en) 2015-07-22 2015-07-22 A kind of preparation method and application of Liuwei Dihuang Wan

Country Status (1)

Country Link
CN (1) CN105055769B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104225167A (en) * 2014-10-17 2014-12-24 中国人民解放军军事医学科学院毒物药物研究所 Application of six-ingredient rehmannia soup extractive in treatment of dementia or cognition impairment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104225167A (en) * 2014-10-17 2014-12-24 中国人民解放军军事医学科学院毒物药物研究所 Application of six-ingredient rehmannia soup extractive in treatment of dementia or cognition impairment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
赵婧: "六味地黄丸及其4入血成分配伍对大鼠前脂肪细胞增殖、分化作用的研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 *

Also Published As

Publication number Publication date
CN105055769B (en) 2017-11-10

Similar Documents

Publication Publication Date Title
CN103784738B (en) A kind of vegetable composition extracting method containing Lepidinm meyenii Walp and application
CN103816368B (en) A kind of vegetable composition extracting method containing Radix Ginseng and application
CN102988577B (en) Preparation method and application of brain-soothing hypertension pill
CN103860802A (en) Preparation method and application of Jieguqili tablet
CN103494885B (en) A kind of preparation method of TONGXIAO BIYAN PIAN and application
CN104940426A (en) Preparation method and application of osteoproliferation removal tablets
CN105030868A (en) Extraction method for plant composition containing silybum marianum and application of plant composition
CN103520446B (en) A kind of preparation method of the Zijin ball that bonesets and application
CN103494915B (en) Preparation method and application of breast lump dissipating tablet
CN103479749B (en) Preparation method and application of Gegenqinlian tablet
CN105055769A (en) Preparation method and application of Liuwei Dihuang pills
CN105055805A (en) Extraction method and application of herbal composition containing herba andrographitis
CN103494930B (en) A kind of preparation method of FUFANG YUXINGCAO PIAN and application
CN103721136B (en) A kind of preparation method of Yanyan slice and application
CN104887905A (en) Preparation method for six-ingredient rehmannia pills and application thereof
CN105056105A (en) Preparation method and application of Shenmei stomach-nourishing particle (containing ginseng and dark plum)
CN103721071B (en) A kind of preparation method of YULU Baofei bolus and application
CN103610857B (en) A kind of preparation method and application of returning red pill for traumatic injuries
CN105055587A (en) Extraction method and application of plant composition containing ginkgo leaves
CN104997966A (en) Preparation method and application of Xinqin granule
CN104906260A (en) Preparation method and application of wind-expelling and itching-relieving granule
CN104922447A (en) Health improvement capsule preparation method and application
CN105194002A (en) Method for extracting plant composition containing echinacea and application of plant composition
CN103479812B (en) A kind of preparation method of children clearing heat sheet and application
CN103656016B (en) A kind of preparation method of antiasthmatic pill of perilla fruit and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant